PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.\', \'Department of Executive Health Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.\', \'Department of Cell Biology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.\', \'College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.\', \'Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.\', \'Department of Community Medicine, United Arab University, Al Ain, United Arab Emirates.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0247758
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33647017
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • Serum β2-microglobulin levels in Coronavirus disease 2019 (Covid-19): Another prognosticator of disease severity?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all